UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1639) 1639
Book Chapter (17) 17
Magazine Article (5) 5
Book / eBook (2) 2
Web Resource (2) 2
Government Document (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1464) 1464
science & technology (1276) 1276
life sciences & biomedicine (1230) 1230
female (809) 809
male (806) 806
pneumonia (623) 623
aged (616) 616
middle aged (597) 597
infectious diseases (582) 582
adult (539) 539
community-acquired infections - epidemiology (538) 538
community-acquired infections - drug therapy (515) 515
anti-bacterial agents - therapeutic use (419) 419
community-acquired pneumonia (399) 399
biological and medical sciences (392) 392
community-acquired infections - microbiology (389) 389
risk factors (373) 373
medical sciences (368) 368
aged, 80 and over (336) 336
adolescent (305) 305
microbiology (302) 302
general & internal medicine (298) 298
bacterial pneumonia (297) 297
antibiotics (296) 296
community-acquired infections - economics (284) 284
mortality (277) 277
retrospective studies (258) 258
hospitalization (238) 238
health aspects (231) 231
child, preschool (230) 230
child (224) 224
medicine, general & internal (216) 216
infant (213) 213
community-acquired infections - diagnosis (206) 206
research (201) 201
pneumonia, bacterial - drug therapy (192) 192
prospective studies (191) 191
respiratory system (189) 189
epidemiology (188) 188
hospitals (187) 187
pneumonia - drug therapy (185) 185
treatment outcome (182) 182
pharmacology & pharmacy (181) 181
young adult (181) 181
abridged index medicus (180) 180
community-acquired infections (180) 180
incidence (173) 173
analysis (168) 168
community-acquired infections - mortality (168) 168
pneumonia - epidemiology (161) 161
care and treatment (160) 160
research article (158) 158
anti-bacterial agents - economics (154) 154
infections (154) 154
community-acquired infections - therapy (147) 147
pneumonia - economics (142) 142
community-acquired infections - prevention & control (140) 140
severity of illness index (139) 139
pharmacology. drug treatments (133) 133
cross infection - epidemiology (131) 131
anti-bacterial agents - administration & dosage (129) 129
drug therapy (123) 123
drug resistance in microorganisms (119) 119
patients (119) 119
antibiotics. antiinfectious agents. antiparasitic agents (117) 117
bacterial diseases (117) 117
drug resistance, bacterial (117) 117
practice guidelines as topic (116) 116
antibacterial agents (115) 115
pneumonia - therapy (114) 114
public, environmental & occupational health (114) 114
immunology (113) 113
comorbidity (112) 112
internal medicine (111) 111
length of stay (110) 110
staphylococcus aureus (108) 108
pneumonia - diagnosis (107) 107
cross infection - microbiology (106) 106
pediatrics (106) 106
medicine (105) 105
human bacterial diseases (104) 104
anti-bacterial agents - pharmacology (103) 103
children (103) 103
studies (101) 101
public health (100) 100
drug resistance (99) 99
pneumonia - mortality (99) 99
staphylococcal infections - epidemiology (99) 99
hospitalization - statistics & numerical data (98) 98
prevalence (96) 96
cohort studies (95) 95
cost-benefit analysis (95) 95
staphylococcal infections - microbiology (94) 94
streptococcus infections (94) 94
infant, newborn (93) 93
streptococcus pneumoniae (91) 91
adults (90) 90
diagnosis (90) 90
medicine & public health (90) 90
hospitalization - economics (87) 87
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1614) 1614
Spanish (33) 33
Russian (16) 16
French (13) 13
Portuguese (13) 13
Japanese (7) 7
German (4) 4
Chinese (3) 3
Italian (3) 3
Turkish (3) 3
Danish (1) 1
Dutch (1) 1
Hebrew (1) 1
Polish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical orthopaedics and related research, ISSN 0009-921X, 7/2013, Volume 471, Issue 7, pp. 2383 - 2399
Surgical Orthopedics | Medicine & Public Health | Sports Medicine | Orthopedics | Surgery | Conservative Orthopedics | Medicine/Public Health, general | Life Sciences & Biomedicine | Science & Technology | Community-Acquired Infections - diagnosis | Community-Acquired Infections - therapy | Community-Acquired Infections - transmission | Hospital Costs | Cross Infection - economics | Humans | Orthopedic Procedures - adverse effects | Infection Control - methods | Cost Savings | Cross Infection - transmission | Staphylococcal Infections - microbiology | Surgical Wound Infection - transmission | Cross Infection - prevention & control | Mass Screening - economics | Community-Acquired Infections - economics | Surgical Wound Infection - economics | Anti-Infective Agents - therapeutic use | Treatment Outcome | Staphylococcal Infections - therapy | Staphylococcal Infections - transmission | Surgical Wound Infection - prevention & control | Staphylococcal Infections - diagnosis | Staphylococcal Infections - economics | Cost-Benefit Analysis | Cross Infection - microbiology | Surgical Wound Infection - diagnosis | Cross Infection - diagnosis | Orthopedic Procedures - economics | Staphylococcal Infections - prevention & control | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Program Evaluation | Surgical Wound Infection - microbiology | Community-Acquired Infections - microbiology | Infection Control - economics | Online health care information services | Orthopedic surgery | Health aspects | Analysis | Staphylococcal infections | Staphylococcus aureus | Index Medicus | Abridged Index Medicus | Survey
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 9/2012, Volume 55, Issue 6, pp. 807 - 815
Hospital costs | Hospitals | Cost estimates | Antimicrobials | Hospital admissions | Urinary tract infections | Infections | Censorship | ARTICLES AND COMMENTARIES | Staphylococcus aureus | Length of stay | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Cross Infection - economics | Community-Acquired Infections - epidemiology | Length of Stay - economics | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Drug Resistance, Bacterial | Bacteremia - mortality | Male | Urinary Tract Infections - economics | Bacteremia - economics | Pneumonia, Bacterial - economics | Case-Control Studies | Bacteremia - microbiology | Hospital Charges - statistics & numerical data | Pneumonia, Bacterial - mortality | Aged, 80 and over | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Bacterial Infections - microbiology | Length of Stay - statistics & numerical data | Cross Infection - epidemiology | Databases, Factual | Community-Acquired Infections - mortality | Pneumonia, Bacterial - microbiology | Bacterial Infections - economics | Community-Acquired Infections - economics | Pneumonia, Bacterial - epidemiology | Urinary Tract Infections - epidemiology | Health Care Costs | Cross Infection - microbiology | Bacterial Infections - epidemiology | Survival Analysis | Bacteremia - epidemiology | New York City - epidemiology | Aged | Community-Acquired Infections - microbiology | Bacterial Infections - mortality | Infection | Blood-borne diseases | Care and treatment | Economic aspects | Research | Drug resistance | Medical care, Cost of | Hospitalization | Health care expenditures | Bacterial infections | Incentives | Mortality | Index Medicus | and Commentaries
Journal Article
Journal of diabetes and its complications, ISSN 1056-8727, 2015, Volume 29, Issue 2, pp. 192 - 195
Endocrinology & Metabolism | Infection | Economics | Hospitalization | Emergency department | Diabetes mellitus | Life Sciences & Biomedicine | Science & Technology | Community-Acquired Infections - therapy | United States - epidemiology | Pneumonia - therapy | Community-Acquired Infections - epidemiology | Humans | Sepsis - complications | Skin Diseases, Infectious - epidemiology | Urinary Tract Infections - economics | Diabetes Complications - therapy | Urinary Tract Infections - complications | Incidence | Health Care Costs - trends | Pneumonia - economics | Skin Diseases, Infectious - economics | Diabetes Complications - epidemiology | Community-Acquired Infections - complications | Retrospective Studies | Skin Diseases, Infectious - therapy | Insurance, Health | Databases, Factual | Skin Diseases, Infectious - complications | Length of Stay | Emergency Service, Hospital | Sepsis - economics | Costs and Cost Analysis | Pneumonia - epidemiology | Community-Acquired Infections - economics | Sepsis - epidemiology | United States Agency for Healthcare Research and Quality | Diabetes Complications - economics | Urinary Tract Infections - epidemiology | Patient Acceptance of Health Care | Hospitalization - trends | Sepsis - therapy | Pneumonia - complications | Urinary Tract Infections - therapy | Cohort Studies | Hospitalization - economics | Diabetics | Utilization | Analysis | Medical care | Cross infection | Diabetes | Nosocomial infections | Health aspects | Diabetes therapy | Medical care, Cost of | Index Medicus | Diabetes Mellitus | Emergency Department
Journal Article
BMC infectious diseases, ISSN 1471-2334, 05/2017, Volume 17, Issue 1, pp. 358 - 358
ESBL | Antibiotic | ICU | DDD | MRSA | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Cross Infection - economics | Prospective Studies | Antibiotic Prophylaxis - statistics & numerical data | Community-Acquired Infections - epidemiology | Romania - epidemiology | Humans | Middle Aged | Intensive Care Units - economics | Intensive Care Units - statistics & numerical data | Male | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Community-Acquired Infections - drug therapy | Female | Staphylococcal Infections - microbiology | beta-Lactamases - metabolism | Cross Infection - epidemiology | Anti-Bacterial Agents - economics | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Community-Acquired Infections - economics | Methicillin-Resistant Staphylococcus aureus - drug effects | Anti-Infective Agents - therapeutic use | Klebsiella Infections - microbiology | Cross Infection - drug therapy | Klebsiella Infections - economics | Staphylococcal Infections - economics | Cross Infection - microbiology | Anti-Infective Agents - economics | Antibiotic Prophylaxis - economics | Community-Acquired Infections - microbiology | Drug Resistance, Multiple, Bacterial - drug effects | Preoperative Period | Drug resistance in microorganisms | Anti-infective agents | Usage | Critical care medicine | Analysis | Medical care, Cost of | Klebsiella | Therapy | Costs | Pneumonia | Intensive care | Laboratories | Communities | Statistical methods | Drug resistance | Devices | Density | Antiinfectives and antibacterials | Incidence | Bacteria | Evolution | Nosocomial infections | Drug dosages | Public health | Consumption | Statistical analysis | Multidrug resistance | Antimicrobial agents | Patients | Statistics | Empirical analysis | Pathology | Hospitals | Antibiotics | Surveillance | Foreign exchange rates | Data collection | Sepsis | Index Medicus
Journal Article
Journal Article
BMC infectious diseases, ISSN 1471-2334, 03/2013, Volume 13, Issue 1, pp. 112 - 112
Journal Article